Unsu Jung

Array ( [id] => 6245895 [patent_doc_number] => 20100136062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'USE OF EPIDERMAL GROWTH FACTOR FOR THE MORPHOFUNCTIONAL RESTORATION OF PERIPHERAL NERVES IN DIABETIC NEUROPATHY' [patent_app_type] => utility [patent_app_number] => 12/443837 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8371 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136062.pdf [firstpage_image] =>[orig_patent_app_number] => 12443837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367112 [patent_doc_number] => 20090304671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Method of treating endothelial dysfunction' [patent_app_type] => utility [patent_app_number] => 12/311130 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21355 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304671.pdf [firstpage_image] =>[orig_patent_app_number] => 12311130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786330 [patent_doc_number] => 20080139659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'METHODS FOR TREATING NEURAL CELL SWELLING' [patent_app_type] => utility [patent_app_number] => 11/857547 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22742 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139659.pdf [firstpage_image] =>[orig_patent_app_number] => 11857547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 225063 [patent_doc_number] => 07605247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-20 [patent_title] => 'Nucleic acid molecules encoding a wheat sucrose transporter' [patent_app_type] => utility [patent_app_number] => 11/901765 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11183 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605247.pdf [firstpage_image] =>[orig_patent_app_number] => 11901765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807750 [patent_doc_number] => 20080171328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Screening assays for hedgehog agonists and antagonists' [patent_app_type] => utility [patent_app_number] => 11/894601 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 75590 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171328.pdf [firstpage_image] =>[orig_patent_app_number] => 11894601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338168 [patent_doc_number] => 20090054632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Hydrophobically-modified protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/894745 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 33608 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054632.pdf [firstpage_image] =>[orig_patent_app_number] => 11894745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697865 [patent_doc_number] => 20080220049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins' [patent_app_type] => utility [patent_app_number] => 11/894045 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 44316 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220049.pdf [firstpage_image] =>[orig_patent_app_number] => 11894045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555165 [patent_doc_number] => 08329637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10' [patent_app_type] => utility [patent_app_number] => 11/839676 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8100 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11839676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025793 [patent_doc_number] => 20110053849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'REGULATION OF LITAF MODULATED CYTOKINE PRODUCTION BY A NOVEL P53 SHORT PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/377545 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8199 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053849.pdf [firstpage_image] =>[orig_patent_app_number] => 12377545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392156 [patent_doc_number] => 20090209469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass Composition' [patent_app_type] => utility [patent_app_number] => 12/374569 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37252 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209469.pdf [firstpage_image] =>[orig_patent_app_number] => 12374569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4905824 [patent_doc_number] => 20080115238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'HEDGEHOG INHIBITOR ASSAY' [patent_app_type] => utility [patent_app_number] => 11/828406 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16647 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20080115238.pdf [firstpage_image] =>[orig_patent_app_number] => 11828406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549277 [patent_doc_number] => 08324158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Methods for inhibiting CLC-2 channel with GATX2' [patent_app_type] => utility [patent_app_number] => 12/373556 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 22 [patent_no_of_words] => 24399 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046515 [patent_doc_number] => 20070265189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/775642 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 123 [patent_no_of_words] => 48577 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265189.pdf [firstpage_image] =>[orig_patent_app_number] => 11775642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271094 [patent_doc_number] => 20090074870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Alteration of cell membrane for new functions' [patent_app_type] => utility [patent_app_number] => 11/819080 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9231 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074870.pdf [firstpage_image] =>[orig_patent_app_number] => 11819080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6219997 [patent_doc_number] => 20100055092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Preventive or Remedy for Inflammatory Disease' [patent_app_type] => utility [patent_app_number] => 12/303684 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12858 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055092.pdf [firstpage_image] =>[orig_patent_app_number] => 12303684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123481 [patent_doc_number] => 07705119 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-27 [patent_title] => 'Compositions and methods useful for treating circulatory and hypovolemic shock' [patent_app_type] => utility [patent_app_number] => 11/759013 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13483 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705119.pdf [firstpage_image] =>[orig_patent_app_number] => 11759013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146692 [patent_doc_number] => 08163699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Method for the treatment of valvular disease' [patent_app_type] => utility [patent_app_number] => 12/227872 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10167 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163699.pdf [firstpage_image] =>[orig_patent_app_number] => 12227872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899310 [patent_doc_number] => 20080118924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 11/752135 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17753 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118924.pdf [firstpage_image] =>[orig_patent_app_number] => 11752135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740550 [patent_doc_number] => 08106013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'ABC transporter ligand GATX1' [patent_app_type] => utility [patent_app_number] => 12/299881 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26790 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106013.pdf [firstpage_image] =>[orig_patent_app_number] => 12299881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509850 [patent_doc_number] => 20110256091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Antibody-Targeted Cytokines for Therapy' [patent_app_type] => utility [patent_app_number] => 12/227060 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10053 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256091.pdf [firstpage_image] =>[orig_patent_app_number] => 12227060 [rel_patent_id] =>[rel_patent_doc_number] =>)